Hamilton Morris

Hamilton Morris, a chemist and filmmaker renowned for "Hamilton's Pharmacopeia," teams up with Dr. Mark Plotkin, an ethnobotanist and president of the Amazon Conservation Team. Together, they delve into the rich history of psychoactive substances, debating the merits of synthetic versus natural options. They explore microdosing, the mysteries of 5-MeO-DMT, and the ecological implications of interest in the Sonoran Desert Toad. Morris and Plotkin emphasize the importance of open dialogue in both conservation and psychedelic research, while reflecting on Timothy Leary's lasting influence.

Hamilton Morris, a journalist and creator of 'Hamilton's Pharmacopeia,' dives deep into the world of psychedelics and drug culture. He discusses DARPA's psychedelic research aimed at treating PTSD and the intriguing use of toad venom as a natural vaccine. The conversation takes a sharp turn as Morris reflects on VICE's downfall and explores the complexities of addiction, contrasting kratom with opioids. Listeners will enjoy his insights on the social constructs of drug perception and the emerging controversies in psychedelic research.

Chris Glenn shares his personal journey with Kratom and Tianeptine addiction, highlighting the emotional struggles linked to dependency. Oliver Gruntman, a clinical expert, discusses the safety concerns and market risks surrounding Kratom's unregulated use. Hamilton Morris provides insights into the misconceptions about Tianeptine, stressing its addictive qualities and regulatory challenges. Together, they explore the evolving American drug culture, the need for better consumer education, and the vital role of pharmacists in public health.

Hamilton Morris, creator and host of "Hamilton's Pharmacopeia," dives into the fascinating world of psychedelics and their therapeutic potential. He discusses the complexities of psychedelic research, funding hurdles, and the shifting public perceptions surrounding substances like psilocybin and LSD. The conversation also touches on the societal stigma of drug use, advocating for compassion and understanding. Additionally, Morris explores the role of personal autonomy in substance consumption and critiques the paradox of regulations around personal enjoyment, like music and tobacco.

Hamilton Morris, a chemist, journalist, and documentary filmmaker, delves into the intricate world of psychoactive substances. He critiques the media's portrayal of fentanyl and discusses the politicization of addiction. The conversation also touches on the complexities of vaping and societal perceptions that shape drug narratives. Morris shares his journey from chemistry to documentary filmmaking, exploring challenges in drug policy and the influence of corporate interests on distribution. The light-hearted talks about the 'Philadelphia Nitrous Mafia' add humor to the insightful dialogue.

Hamilton Morris, a chemist and filmmaker known for exploring psychedelics, dives deep into the transformative world of psychoactive substances. He discusses the therapeutic potential of iboga for addiction, sharing personal rituals from Central West Africa. The conversation also explores the cultural dynamics of psychedelics, the ethical sourcing of these substances, and the significance of ritual in psychedelic experiences. Morris highlights the ongoing evolution in drug research and the importance of responsible practices in this intriguing field.

Hamilton Morris (TW: @hamiltonmorris, IG: @hamiltonmorris) is a writer, documentarian, and scientific researcher who currently studies the chemistry and pharmacology of tryptamines at the University of the Sciences in Philadelphia.His writing has been featured in Harper’s Magazine, Playboy, and Vice, and he is the creator of the television series Hamilton’s Pharmacopeia, which recently completed its second season, and it is absolutely one of my favorite series of the last five years.Hamilton is exceptionally good at explaining complex subjects simply and making science sexy, as you’ll discover in this episode.Enjoy!This episode is brought to you by Inktel. Ever since I wrote The 4-Hour Workweek, I’ve been frequently asked about how I choose to delegate tasks. At the root of many of my decisions is a simple question: “How can I invest money to improve my quality of life?” Or “how can I spend moderate money to save significant time?”Inktel is one of those investments. They are a turnkey solution for all of your customer care needs. Their team answers more than 1 million customer service requests each year. They can also interact with your customers across all platforms, including email, phone, social media, text, and chat.Inktel removes the logistics and headache of customer communication, allowing you to grow your business by focusing on your strengths. And as a listener of this podcast, you can get up to $10,000 off your start-up fees and costs waived by visiting inktel.com/tim. That’s inktel.com/tim.This episode is also brought to you by Leadership: In Turbulent Times by the ever-amazing, Pulitzer Prize-winning author Doris Kearns Goodwin — who you may have heard on this podcast recently (if not, I recommend checking out our conversation at tim.blog/doris).Leadership: In Turbulent Times is a culmination of five decades of acclaimed studies in presidential history, which offers an illuminating exploration of the early development, growth, and exercise of leadership drawing from the experiences of four presidents — Lincoln, Theodore Roosevelt, FDR, and LBJ. Goodwin asks and answers questions like: Are leaders born or made? Where does ambition come from? How does adversity affect the growth of leadership? Does the leader make the times, or do the times make the leader? This seminal work provides an accessible and essential roadmap for aspiring and established leaders in every field. I highly recommend Leadership: In Turbulent Times, and you can find out more about it at doriskearnsgoodwin.com.***If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests. I also love reading the reviews!For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim’s email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Interested in sponsoring the podcast? Visit tim.blog/sponsor and fill out the form.Discover Tim’s books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A LIVE DTFH recorded at the Bell House in Brooklyn with Hamilton Morris (Hamilton's Pharmacopia, VICE) and Emil Amos (Holy Sons, OM).

Hamilton Morris, a renowned chemist, filmmaker, and journalist, dives into the crucial issues surrounding the DEA's attempts to classify DOI and DOC as Schedule I substances. He shares his firsthand experiences from a DEA hearing, exposing the bureaucratic mess that stifles psychedelic research. Morris discusses the safety profiles of these compounds, the frustrating exclusion of expert testimonials in court, and the environmental concerns tied to Sonoran Desert toad venom use. This eye-opening conversation emphasizes the pressing need for improved drug policy and advocacy for scientific progress.

Hamilton Morris, a prominent journalist and scientist known for his exploration of psychedelics in "Hamilton's Pharmacopeia," joins to unravel the shocking truth behind the FDA’s rejection of MDMA-assisted therapy. He reveals a covert agenda aimed at blocking this revolutionary treatment, highlighting the intertwining of politics, capitalism, and misinformation. The conversation dives into the misconceptions about safety concerns and the suppression of potentially life-changing therapies, emphasizing the urgent need for a reevaluation of how society approaches mental health solutions.